Different approaches in the gene therapy of cancer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The requirements of gene therapy for cancer are distinct from those of gene therapy for hereditary monogenic diseases. In cancer the aim is to kill, not cure tumour cells. Also issues such as duration of gene expression and immunogenicity of vector systems are of less relevance than efficiency of delivery to all tumour cells. In this light, we discuss the vector systems currently available and the methods to target transgenes to tumour cells. In view of the current limitations in both vector systems and targeting of tumours, we discuss the strategies that may be applied to increase the effectiveness of inefficient delivery, such as immune activation, bystander cytotoxicity and replication-competent viruses.

Original languageEnglish (US)
Pages (from-to)225-236
Number of pages12
JournalFORUM - Trends in Experimental and Clinical Medicine
Volume9
Issue number3
StatePublished - 1999

Fingerprint

Genetic Therapy
Neoplasms
Inborn Genetic Diseases
Virus Replication
Transgenes
Gene Expression

Keywords

  • Cancer
  • Gene therapy
  • Immunotherapy
  • Replication-competent
  • Suicide gene
  • Targeting
  • Vector

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Different approaches in the gene therapy of cancer. / Gough, M. J.; Vile, Richard Geoffrey.

In: FORUM - Trends in Experimental and Clinical Medicine, Vol. 9, No. 3, 1999, p. 225-236.

Research output: Contribution to journalArticle

@article{b1e8a4f4029a4ca28cc6ce44e0f21dc3,
title = "Different approaches in the gene therapy of cancer",
abstract = "The requirements of gene therapy for cancer are distinct from those of gene therapy for hereditary monogenic diseases. In cancer the aim is to kill, not cure tumour cells. Also issues such as duration of gene expression and immunogenicity of vector systems are of less relevance than efficiency of delivery to all tumour cells. In this light, we discuss the vector systems currently available and the methods to target transgenes to tumour cells. In view of the current limitations in both vector systems and targeting of tumours, we discuss the strategies that may be applied to increase the effectiveness of inefficient delivery, such as immune activation, bystander cytotoxicity and replication-competent viruses.",
keywords = "Cancer, Gene therapy, Immunotherapy, Replication-competent, Suicide gene, Targeting, Vector",
author = "Gough, {M. J.} and Vile, {Richard Geoffrey}",
year = "1999",
language = "English (US)",
volume = "9",
pages = "225--236",
journal = "FORUM - Trends in Experimental and Clinical Medicine",
issn = "1121-8142",
publisher = "Scuola superiore di oncologia e scienze biomediche",
number = "3",

}

TY - JOUR

T1 - Different approaches in the gene therapy of cancer

AU - Gough, M. J.

AU - Vile, Richard Geoffrey

PY - 1999

Y1 - 1999

N2 - The requirements of gene therapy for cancer are distinct from those of gene therapy for hereditary monogenic diseases. In cancer the aim is to kill, not cure tumour cells. Also issues such as duration of gene expression and immunogenicity of vector systems are of less relevance than efficiency of delivery to all tumour cells. In this light, we discuss the vector systems currently available and the methods to target transgenes to tumour cells. In view of the current limitations in both vector systems and targeting of tumours, we discuss the strategies that may be applied to increase the effectiveness of inefficient delivery, such as immune activation, bystander cytotoxicity and replication-competent viruses.

AB - The requirements of gene therapy for cancer are distinct from those of gene therapy for hereditary monogenic diseases. In cancer the aim is to kill, not cure tumour cells. Also issues such as duration of gene expression and immunogenicity of vector systems are of less relevance than efficiency of delivery to all tumour cells. In this light, we discuss the vector systems currently available and the methods to target transgenes to tumour cells. In view of the current limitations in both vector systems and targeting of tumours, we discuss the strategies that may be applied to increase the effectiveness of inefficient delivery, such as immune activation, bystander cytotoxicity and replication-competent viruses.

KW - Cancer

KW - Gene therapy

KW - Immunotherapy

KW - Replication-competent

KW - Suicide gene

KW - Targeting

KW - Vector

UR - http://www.scopus.com/inward/record.url?scp=0032719240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032719240&partnerID=8YFLogxK

M3 - Article

C2 - 10504170

AN - SCOPUS:0032719240

VL - 9

SP - 225

EP - 236

JO - FORUM - Trends in Experimental and Clinical Medicine

JF - FORUM - Trends in Experimental and Clinical Medicine

SN - 1121-8142

IS - 3

ER -